bofA-ML
CARILLION-New financing & deferral of some pension contributions.(50-55).+20-30%
MORPHOSYS - FDA Breakthrough designation for antibody MOR208.(77.4-81.1)..+5-10%
AMS -Q3 sales €262.6m,EBIT margin 13.25%. Confirm guidance.(68.9-70.19)....+5-7%
SERCO - Acquires BTP systems for $20m.To be done by y/e and accretive.(119.7)+3%
HUNTING - continued improving trends in some US onshore markets (470p).......+3%
COVESTRO - Q3 EBIT beat, buyback of up to €1.5bn.Positive outlook(73.56).....+2%
WHITBREAD - Premier Inn LfL 3.6%,Restaurants 1.1%,Costa 0.6% (3980-4020)...+1-2%
LOGITECH - Q2 sales USD634m (c622m), EBIT 60m (c54m),confirms FY...(36.98)...+2%
COMMERZBANK - FT says hires GS/Rothschild to advise on potl takeovers(11.65).+2%
STJ - AUM £85.7bln vs cons £85.95,Net flows £2.36bln,reit targets (1182).....+1%
NOVARTIS - Sales $12.41b,core EBIT 3.38b,group outlook reaffirmed..(86)......+1%
SCHINDLER - 9m orders CHF8.08bn,EBIT 860m,FY rev growth 3%-5% - unch.(225.23)+1%
MINERS - Small better in Oz, Copper attempts to re-test ytd highs..........+0.5%
ANGLO - Production solid.Diamonds, Iron ore, Copper strong.(1451.22).......+0.5%
BUNZL - Rev growth (cFX) of +11% yoy,+5.5% org and 6% from M&A.(2256p)......UNCH
SAIPEM - 3Q17 rev €2.3bn 6% below cons. EBIT 8% beat. Guidance FY 17 unch...UNCH
RANDSTAD - Q3 results IN LINE; growth in early Oct similar to Q3......(54.7)UNCH
ATOS - Q3 revs bang in-line,guidance reit driven by France..................UNCH
BASF - Q3 3% beat all on cyclical.Mix poor.Driven by chems/O&G.Been strong..UNCH
SWEDBANK - Solid quarter on NII but capital miss a slight disappointment....UNCH
ESSILOR - Q3 sales inline with consensus at 5.9% cFX.Been strong. (99.99.....-1%
LUXOTTICA-Q3 rev growth 0.8%.50bp hurricane impact.Guidance optimistic.(45.8)-1%
BNP/CRED AG - FT reports BNP/Cred AG most likely suitor for CBK..............-1%
DB1-Frankfurt court refuses approve settlement btwn prosecutors & CEO(91.25).-1%
CARPETRIGHT - H1 profit to be lower than prior year. LFL sales rise 0.8%(176)-2%
BOLIDEN - EBIT light, +32% YoY but looks about 20% MISS.CEO to retire(298.6).-3%
FUCHS PETROLUB-Cuts EBIT forecast to'just below or flat'YoY from +1-5%(47.45)-5%
CS
AMS +7-10% Q3 sales of €263m cons €279m, Q4 guidance well above
Anglos UNCH Iron ore, coal and diamonds slightly better, platinum worse
Atos -1% Q3 Sales EU 3.0bln. Q3 Orders EU 2.89bln. Confirms 2017
BASF R Q3 Rev EU 15.3bln est EU 15.0bln, Maintains 2017
Boliden -7-10% Q3 1.74bn Cons 2.37m, higher costs, CEO change
Bunzl M/P Rev growth inline, performance inline with expectations
Caxiabank +1% Low quality beat driven by Trading, capital better
Covestro +3% Q3 Sales Eu 3,5bn vs cons 3,4bn, Reiterates FY17
Dialog +2-3% Positive read from AMS numbers
Electrolux -3-4% Negative read from Whirlpool warning after US close
Essilor M/P 3Q sales 1.75bln con 1.76bln, confirms guidance
Fuchs -5% Cut guidance - see's Ebit just below last year
Flow Traders -2% Adj ebitda €7.6m vs cons €8.8m, tax provisions help net
GKN M/P Announced in numerous papers re: merger spec
Gurit M/P Guiding to low single digit rev growth, cons +1.4%
Huber -2-3% Orders slightly ahead, sales guidance light
Hunting +2-3% Revs and EBITDA on track, Capex under control
Idorsia M/P Q3 op loss CHF68m is slightly better than cons
Leoni -3-4% CEO Dieter Bellé agreed on his early retirement
Logitech +0.5% Strong Q2 FY18 results, guidance unchanged, cashflow weak
Luxottica +1-2% 3Q net sales EU2.15B, est EU2.17B, confirms outlook
Miners +0.5% Copper +1.55%, Brent UNCH, Iron Ore +0.75%, China UNCH
Morphosys + 0% FDA Breakthrough Therapy designation for antibody MOR208
Novartis UNCH Q3 Core EPS $1.29 est %1.25. 2017 Outlook confirmed
Randstad +0.5% EBITA 287.5m vs 288m cons, EPS 1.10 vs 1.11
Schindler +1-2% Organic growth ahead, orders 2.4% ahead of cons
St James +1-2% Net inflows of £2.36bn, FUM to £85.7bn
Swedbank -1-2% Slightly ahead, lower loan losses, capital 23.9 vs 24.4%
Tieto +1% 3Q op profit 41.2mln cons 39.4mln, keep FY outlook
Whitbread -1% 1H revs GBP1.67B, est GBP1.67B, LFL's weaker, confirms FY
Worldline M/P 3Q revs Eu386m cons 405m, Confirms FY tgts
Investec
UK
UK
* ANGLO'S-Q3.In line to sml beat.Higher Kumba g'ance see risks to upside....+1%
* BLOOMSBURY-H1.#'s ahead, children strong & Tax better.U/G FY18&19 EPS...+1-2%
* BUNZL-Update.Rev +11%. Sees further acquisition in coming months..........+1%
* CARILLION-Update.Sale of Healthcare facilities(£50.1m)New credit line..+5-10%
* CARPETRIGHT-Update.H1 below last yr.Sees stronger H2. FY within range.....-1%
* GB GROUP-Update.+tive pre-close, upgrading HY operating pft targets.......+2%
* HUNTING-Q3.Continued strengh, FY Rev $700m. Sees modest PTP.............+2-3%
* INTL.PERS.FNCE-Q3.#'s in line, maintains FY g'ance. Weaker outlook........-1%
* MCBRIDE-Update.FY remains on track but reits will be H2 weighted.Tra&Arr..-2%
* SERCO-CLLN HC acq's(£50.1m) & BTP Sysytems for $20m. New Debt facilities..+1%
* ST JAMES'S PL.-Q3.FuM £85.7b, looks ahead. Confident outlook..............+1%
* TELIT COMMS-Completes Certification for LTE Cat 1,will enable ramp up...+3-5%
* VECTURA-Breezhaler continues to deliver strong U/L growth.................+1%
* WHITBREAD-H1.Rev I/L PTP ahead. Maintains full year outlook..............+1/2%
EU
* AMS-Q3 rev 6% miss but Q4 guidance more than offsets (12% ahead of cons)...+6%
* ATOS-Q3 rev in line, +2.5% organically, confirms targets, strong y'day.....U/C
* BASF-Q3 revs 2% beat, ebit in line, keeps FY growth forecasts..............U/C
* BOLIDEN-big Q3 miss,prodn disturbances,lower grades,CEO leave mid 2018.....-2%
* CAIXABANK-Q3 NII in line. Domestic issues dominate here, not no's..........-1%
* COMMERZBANK-said to hire Goldman, Rothschild as advisers (FT)..............+1%
* COVESTRO-Q3 sales 2% ahead, net inc and ebitda well ahead, reits FY........+2%
* DOMETIC-Q3 organic rev +11%, ebit well ahead, committed to outlook.........+2%
* ELECTROLUX-Whirlpool cuts FY view, shares -6.5% after hours................-2%
* ENEL-Q3 op data not great but likely trades ok ahead of results and CMD....-1%
* ESSILOR-Q3 sales small miss, reits FY......................................-1%
* FUCHS-9m no's out, cuts FY ebit est to small down vs +1%-5%................-4%
* IDORSIA-Q3 loss better than expected, FY guidance in line/slightly better..+1%
* LOGITECH-Q2 sales 1% beat, reaffirms FY....................................-1%
* LUXOTTICA-Q3 rev 1% miss, confirms FY outlook, likely low end..............-2%
* NOVARTIS-Q3 eps 3% beat,confm o/look,giving Alcon time to turn round(-ive).+1%
* RANDSTAD-Q3 rev +9% organically, sees Q4 margin stable, strong into........U/C
* SAIPEM-Q3 miss but FY guidance in line/slightly ahead?, weak into..........+2%
* SCHINDLER-9m no's,FY rev guidance looks in line,profit ahead, strong into..U/C
* SWEDBANK-no's and outlook in line, been weak into numbers..................+1%
MS
LUX IM -1% WEAK Q3 SALES IN-LINE WITH LOW CONS. EXPECTATIONS; RETAIL LFL -5.1% v CONS -3.5% WILL BE TAKEN NEGATIVELY.
LUX IM -1% WEAK Q3 SALES IN-LINE WITH LOW CONS. EXPECTATIONS; RETAIL LFL -5.1% v CONS -3.5% WILL BE TAKEN NEGATIVELY.
RAND NA -1% ORG GROWTH BEATS CONS BY 1% BUT FCF WEAK, WORKING CAPITAL HIGH; OUTLOOK SEES CONTINUATION OF VOLUME GROWTH BUT TOUGHER COMPS IN Q4. TRAVEL AND ARRIVE.
EI FP +1% ORG SALES GROWTH 2.5% VS 2.6%, US HURRICANES SEEN AS ONLY HAVING MINOR IMPACT TO FY GROWTH (50bp). UPDATE ON LUX MERGER EXPECTED ON CALL.
BAS GY +0.5% SALES BEAT (1.5%), ADJ EBIT BEAT (3%), EXPECTS GROWTH IN SALES. STRONG INTO NUMBERS
SWEDA SS UNCH 4% PPOP BEAT WITH STRONG NII & COSTS BUT BALANCED BY 50BPS CET1 MISS
Macquarie
* Bunzl BNZL- Inline, more acquisitions planned. Unch
Macquarie
* Bunzl BNZL- Inline, more acquisitions planned. Unch
* Carpetright CPR- Keeps FY guidance but reliant on strong H2, UK & European sales volatile but recently encouraging; -2-3%
* Carillion CLLN- New Credit facilities agreed & disposal of Healthcare Business for £50.1m. Updated Guidance unchanged, continues to assess options for capital structure……+20% ?
* Hays- Positive read-X from RAND NA, +0.5%
* Hunting HTG- Expects FY Rev’s of $700m top end of est’s, Ebitda top end also. +3-5%
* Kosmos KOS- Buys Hess’s interests in Gulf of Guinea fields for $650m of which Kosmos pays $240m. +1%
* Saga- Chairman Andrew Goodsell retiring in 2018. Unch
* Serco SRP- Buys US defence engineering services firm for $20m & Healthcare Division from Carillion for £50.1m. Unch
* St. James STJ- FUM £85.7bn slightly ahead Macq est $85m. confident outlook. Unch
* Whitbread WTB- Keeps FY guidance, cautious on current environment; +1%
Jefferies
NOVN called +1%.. - pretty decent quality, should be up rel today
NOVN called +1%.. - pretty decent quality, should be up rel today
MOR GY +10% aft-hrs... received FDA Breakthrough Therapy designation for its antibody MOR208
LEONI -3% aft-hrs.. CEO to retire early on January 31, 2018
FUCHS PETROLUB -5% after-hrs.. warning.. now sees FY17 EBIT 'just below or flat' yoy from up 1-5%